Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1.18M | $8.0M | 12.32% | +234.4K | 2026-03-31 |
| ORBIMED ADVISORS LLC | 1.03M | $7.0M | 10.71% | -- | 2026-03-31 |
| FRANKLIN RESOURCES INC | 626.6K | $4.0M | 6.53% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 381.8K | $2.0M | 3.98% | +274.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 336.5K | $2.0M | 3.51% | -- | 2026-03-31 |
| Woodline Partners LP | 313.1K | $2.0M | 3.26% | -311.9K | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 274.4K | $1.0M | 2.86% | -- | 2026-03-31 |
| Prosight Management, LP | 250.2K | $1.0M | 2.61% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 232.6K | $1.0M | 2.42% | -10.4K | 2026-03-31 |
| Stonepine Capital Management, LLC | 222.0K | $1.0M | 2.31% | +1.9K | 2026-03-31 |
